Kejun Deng
Overview
Explore the profile of Kejun Deng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
541
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li R, Yu J, Ye D, Liu S, Zhang H, Lin H, et al.
Toxins (Basel)
. 2025 Feb;
17(2).
PMID: 39998095
Conotoxins, a diverse family of disulfide-rich peptides derived from the venom of species, have gained prominence in biomedical research due to their highly specific interactions with ion channels, receptors, and...
2.
Liu S, Shi T, Yu J, Li R, Lin H, Deng K
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337334
Bitter peptides are small molecular peptides produced by the hydrolysis of proteins under acidic, alkaline, or enzymatic conditions. These peptides can enhance food flavor and offer various health benefits, with...
3.
Lv L, Li Q, Wang K, Zhao J, Deng K, Zhang R, et al.
J Med Chem
. 2024 Apr;
67(9):7385-7405.
PMID: 38687956
Anemoside B4 (AB4), a triterpenoidal saponin from , shows significant anti-inflammatory activity, and may be used for treating inflammatory bowel disease (IBD). Nevertheless, its application is limited due to its...
4.
Xie G, Chen M, Yang Y, Xie Y, Deng K, Xie L
Food Chem
. 2024 Apr;
451:139431.
PMID: 38663248
The black morel (Morchella sextelata) is a valuable edible and medicinal mushroom appreciated worldwide. Here, lipidomic profiles and lipid dynamic changes during the growth of M. sexletata were analyzed using...
5.
Qin J, Yang Y, Ai C, Ji Z, Chen W, Song Y, et al.
Int J Antimicrob Agents
. 2024 Mar;
63(5):107122.
PMID: 38431108
Background: With increasing antibiotic resistance and regulation, the issue of antibiotic combination has been emphasised. However, antibiotic combination prescribing lacks a rapid identification of feasibility, while its risk of drug...
6.
Xie X, Wu C, Hao Y, Wang T, Yang Y, Cai P, et al.
Front Endocrinol (Lausanne)
. 2024 Jan;
14:1301093.
PMID: 38179301
Diabetes is a chronic metabolic disease, and its therapeutic goals focus on the effective management of blood glucose and various complications. Drug combination therapy has emerged as a comprehensive treatment...
7.
Zou X, Ren L, Cai P, Zhang Y, Ding H, Deng K, et al.
Front Med (Lausanne)
. 2023 Nov;
10:1281880.
PMID: 38020152
Introduction: Hemagglutinin (HA) is responsible for facilitating viral entry and infection by promoting the fusion between the host membrane and the virus. Given its significance in the process of influenza...
8.
Zhang Y, Pan X, Shi T, Gu Z, Yang Z, Liu M, et al.
J Adv Res
. 2023 Oct;
63:35-42.
PMID: 37871773
Introduction: Cytochrome P450 enzymes (P450s) are recognized as the most versatile catalysts worldwide, playing vital roles in numerous biological metabolism and biosynthesis processes across all kingdoms of life. Despite the...
9.
Ren L, Pan X, Ning L, Gong D, Huang J, Deng K, et al.
Curr Comput Aided Drug Des
. 2022 Dec;
19(2):150-161.
PMID: 36567292
Background: Hepatocellular carcinoma (HCC) is the most common liver malignancy where tumorigenesis and metastasis are believed to be tied to the hallmarks of hypoxia and tumor microenvironment (TME). Methods: In...
10.
Yang Y, Gao D, Xie X, Qin J, Li J, Lin H, et al.
Clin Pharmacokinet
. 2022 Nov;
61(12):1749-1759.
PMID: 36369328
Background And Objective: In clinical practice, injectable drug combination (IDC) usually provides good therapeutic effects for patients. Numerous clinical studies have directly indicated that inappropriate IDC generates adverse drug events...